tag:blogger.com,1999:blog-7846766723893890993.post3992228203891042232..comments2024-03-18T02:13:51.846-07:00Comments on Public Relations Problems and Cases: Giulia Carandohttp://www.blogger.com/profile/08958379838925698773noreply@blogger.comBlogger12125tag:blogger.com,1999:blog-7846766723893890993.post-66552528585210120022012-12-11T01:35:16.524-08:002012-12-11T01:35:16.524-08:00I am regular visitor, how are you everybody?
This...I am regular visitor, how are you everybody?<br /><br />This paragraph posted at this site is actually fastidious.<br /><i>Also visit my site</i> - <b><a href="http://www.xxxvideofix.com/video/60049/young-teen-daughter-abuse.html" rel="nofollow">free sex</a></b>Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-26032156526161337412012-12-07T08:15:55.729-08:002012-12-07T08:15:55.729-08:00This text is invaluable. Where can I find out more...This text is invaluable. Where can I find out more?<br /><i>My site</i>: <b><a href="http://www.bhgalleries.com" rel="nofollow">free teen porn</a></b>Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-43634444544118171052009-02-23T07:00:00.000-08:002009-02-23T07:00:00.000-08:00(7 posting recorded at 10 a.m. 2/23/09. All others...(7 posting recorded at 10 a.m. 2/23/09. All others -20 points) NicholsGiulia Carandohttps://www.blogger.com/profile/08958379838925698773noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-22118491358192240742009-02-23T06:52:00.000-08:002009-02-23T06:52:00.000-08:00This comment has been removed by the author.Giulia Carandohttps://www.blogger.com/profile/08958379838925698773noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-86963897565806649642009-02-23T05:28:00.000-08:002009-02-23T05:28:00.000-08:00While the development of the GARDASIL vaccine was ...While the development of the GARDASIL vaccine was a great service to young women, the marketing of it is not. There is a very fine line in terms of ethics with pharmaceutical companies, and Merck may cross it at times with this campaign. Yes, the "one less" message is sticky. However, Merck uses that to exploit older women to get the vaccine when it may not even benefit them. The campaign can be misleading to consumers, as the vaccine is marketed as THE cervical cancer prevention. It gives rise to the idea that if a woman gets the vaccine, then she will not get cervical cancer. Merck hasn't done anything to dispel this myth.Jesshttps://www.blogger.com/profile/16134908262258310916noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-56962648595099447232009-02-22T21:28:00.000-08:002009-02-22T21:28:00.000-08:00The health care side of public relations is one wh...The health care side of public relations is one which must use the highest ethical standards. Because GARDASIL is marketed as the “cervical cancer vaccine,” and this has the possibility of tricking young women into thinking that they are immune from cervical cancer, it makes the company appear to be deceptive. All corporations need to make a profit but when research states that the vaccine is not effective in older women it should not be marketed to that population. <BR/>I have seen many of the GARDASIL commercials and think that they have done a great job at making their messages "sticky." The simplicity of their message makes it easy to remember and the fact that they exploit the mother-daughter relationship appeals to my emotions as a member of their target audience. However, Merck must pay close attention to medical studies about its products and be sure to keep up to date on the research to make sure they are not using unethical marketing techniques.Unknownhttps://www.blogger.com/profile/16001710450512182431noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-68696405106333593162009-02-22T15:47:00.000-08:002009-02-22T15:47:00.000-08:00Merck clearly has its focus on the profit it can g...Merck clearly has its focus on the profit it can gain over the self-interests of its drug consumers. This profit-seeking motive explains their reasoning for starting to target older women who would not benefit from the drug. According to the CBSNews article “New Worries About Gardasil Safety,” there have been 29 deaths reported that are linked to the Gardasil vaccine. I was actually surprised by this because of the positive commercials and “talk” about the Gardasil shots. I feel as though there has been a lot more positive coverage of the Gardasil drug compared to the negative events surrounding it. The CBSNews article also recognized how Merck is now trying to have Gardasil approved for males. Again, this will give Merck another avenue for profit. While, I think that Merck is now looking for ways to increase profit with Gardasil, initially their idea to create Gardasil reflects their desire to help tackle this increasing health problem. Therefore I will give them credit for creating the vaccine, but I think their present motives are leaning more towards profit over public service. <BR/><BR/> In looking at Gardasil’s “One less” campaign, I applaud them. I think the campaign was very successful and convincing of the drug’s abilities to “cure” you from cervical cancer. While the campaign could be considered misleading because of its portrayal of Gardasil as a complete cure from cervical cancer, it was still effective. I have not received the vaccine, but to be honest, after seeing those commercials, it definitely made me want to learn more about the vaccine. After learning more about the company and the vaccine from the case study and the article, it made me realize how affective their campaign was because up to this point I have had only positive feelings regarding the vaccine. Looking at Merck and Gardasil from an advertising/pr view I think they did a fantastic job of marketing their product and shaping a positive image for it. However, ethically and scientifically they need to reevaluate their initial reasons for creating the vaccine and its audiences and acknowledge the effects and fatality stories that relate to the drug. While the company stands by its statement that Gardasil’s benefits outweigh its risks, it needs to focus on how serious the risk might be and communicate this to its publics.Unknownhttps://www.blogger.com/profile/11216519962096343522noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-15606336168239820522009-02-22T15:45:00.000-08:002009-02-22T15:45:00.000-08:00I also don't blame Merck for targeting to a larger...I also don't blame Merck for targeting to a larger audience than it maybe should be because of the scientific debate of the effectiveness of the vaccine. If a business wants to stay in business, targeting to a broader segment in this case is necessary.<BR/>Statistically, it may not help every single person in the older age range but if it even saves one life- then Merck has done its job. Merck never claimed to be miracle workers. They are simply doing thier job and selling pharmacutical drugs that will enhance peoples' quality of life. In a capitalist market, the consumer has to take some responsibilty before investing in a vaccine. If not, then Merck has every right to make money (and perhaps save one's life) of someone who doesn't feel like doing the research prior to putting something in their body. <BR/><BR/><BR/><BR/>My question to the presenters is whether this marketing strategy did infact make up for the decline in sales in July/August of 2008.Giulia Carandohttps://www.blogger.com/profile/08958379838925698773noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-19829545710800724912009-02-22T15:44:00.000-08:002009-02-22T15:44:00.000-08:00This comment has been removed by the author.Giulia Carandohttps://www.blogger.com/profile/08958379838925698773noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-48907963380567925412009-02-22T10:42:00.000-08:002009-02-22T10:42:00.000-08:00Merck has a monopoly on HPV vaccines with their pr...Merck has a monopoly on HPV vaccines with their product Gardasil. I was unaware that Merck has shifted their target audience until I read your case study. I find this to be unethical for a scientific company that is marketing a product that has killed young girls to start selling to an older demographic that has no clear benefits to gain from getting the vaccine. Corporations are always trying to make a profit, but if Merck is doing this at the expense of people’s health this will turn into a public relations problem for the company. A story on CBSnews.com from Feb. 9, 2009 titled New Worries About Gardasil Safety talk about the adverse affects the vaccine has had on young people. A private vaccine safety group compared the adverse events to the Meningitis vaccine also given to young people. Gardasil had up to 30 times higher number of events. <BR/>The Merck commercials “One less” were catchy and made people think this was going to keep them from getting cancer and that is not the case the vaccine is meant to prevent certain strains of the HPV virus linked to cervical cancer. I think this campaign was genius and Gardasil become one of Merck’s top-selling drugs, but when looked at more closely Merck might be more interested in profits than in helping young women. The campaign is misleading especially for young women and girls who are the main audience and the secondary audience their mothers. <BR/>In one of the other comments Michael said “Next thing you know, Merck will be trying to convince men that they can get cervical cancer, or that they should also be vaccinated to HPV because they could otherwise transmit the virus to women.” Merck asked federal regulators to allow the vaccine for use in males to prevent boys from spreading the virus to girls. According to the CBSnews.com article Cervical Cancer Vaccine – For Boys? Jan. 6, 2009 this was always in Merck’s long-term plan for the vaccine to increase the market for the vaccine. <BR/>Merck has caused soci-political issues with it’s vaccine drug companies face public relations crisis because their products can kill people, Tylenol and the cyanide crisis in the 80s is often an example in crisis management. Vaccines are not covered by the media in the same way as a tragic death caused by a drug poisoning a person. Vaccines always have complications and adverse reactions just listen to a Claritin commercial or any other drug commercial. Some are minor, but Gardisal is still new and Merck’s aggressive marketing tactics might cause them problems in the future for now though the controversy over the vaccine gives them free exposure.Unknownhttps://www.blogger.com/profile/18195622066795198713noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-43897013114611580102009-02-22T08:55:00.000-08:002009-02-22T08:55:00.000-08:00Lauren RothbardtMy biggest concern is with Merck’s...Lauren Rothbardt<BR/><BR/>My biggest concern is with Merck’s advertising shift. Why are they shifting their marketing away from the younger end of the demographic in an effort to focus more on nineteen to twenty-six years old if the results of their studies showed that the vaccine was only effective when given prior to infection and not helpful to women who are already infected with HPV? <BR/><BR/>In an article published on MSNBC.com on Nov. 14, 1008, it states that more than 10, 000 teenage girls and young women participated in an anonymous survey on Tyrashow.com and the results show that the average age girls are losing their virginity is 15 years old. Why wouldn’t Merck focus on girls 15 and younger so they can be educated on HPV and GARDASIL before they engage in sexual encounters? The goal of Merck should be to target girls before they have sex so they can get the vaccine first and therefore use it to its’ full effectivenessGiulia Carandohttps://www.blogger.com/profile/08958379838925698773noreply@blogger.comtag:blogger.com,1999:blog-7846766723893890993.post-79378980104559928282009-02-21T23:14:00.000-08:002009-02-21T23:14:00.000-08:00"Also, according to financial site Bloomberg.com, ..."Also, according to financial site Bloomberg.com, Merck is now targeting GARDASIL to women who may not benefit from the vaccine in order to compensate for a decline in sales in July and August 2008."<BR/><BR/>I do agree with the idea that Merck was fulfilling some sort of public service by making such a potentially-lifesaving product available. However, I do think that any pharmaceutical company’s true motive is to make money. In a ‘capitalist’ country like ours, it’s almost to be expected now that the big drug companies will try to sell you things you don’t need. Next thing you know, Merck will be trying to convince men that they can get cervical cancer, or that they should also be vaccinated to HPV because they could otherwise transmit the virus to women. <BR/><BR/>The biggest ‘issue’ with selling a product like the HPV vaccine is that each customer will only need it once. According to an article on medicalnewstoday.com, through a joint venture with Sanofi Pasteur MSD (a European vaccine distributor), Merck has been marketing GARDASIL to 25 European countries for last 2 years. I do think it was a wise move for them to also cover some African countries, especially when they have incredibly high fertility rates (and thus a growing youth) in comparison with the US and most European countries. <BR/><BR/>All in all, I don’t take much issue with Merck trying to blanket a wider age range than perhaps they should. I am a bit more concerned that Merck seems to be stating that HPV is THE cause of cervical cancer. I don’t think that HPV being a “factor in nearly all cases” is enough to make a claim of pure causation.Michaelhttps://www.blogger.com/profile/06328833703933112416noreply@blogger.com